iMedPub Journals
TRANSLATIONAL BIOMEDICINE
2010Vol.1No. 3:3doi: 10:3823/416
© Under License o Creative Commons Attribution 3.0 License This article is available rom:http://www.transbiomedicine.com
nutrient levels will predictably low in patients who are fghtingactive disease due to increased demand, but coupled with ge-netic predisposition issues and a myriad o other issues, levelscan easily become pathological. Micronutrient defciencies areinsidious usually, and recommendations or vitamin and min-eral supplementation or the apparently healthy are oten dis-regarded as superuous. It is unlikely that anyone ever has su-fcient levels o essential micronutrients at all times to meet theunpredictable demands o the body deense systems. Intuitively,it might seem that a low single nutrient level would make littledierence in the whole scheme o lie. However, when just onecellular request goes unflled repercussions are elt throughoutthe entire body and can lead to a myriad o acute and chronicdisease states.Unortunately, body reserves o vitamins and minerals do nothave to be even “out o the reerence range” or “signifcantlylow” in order to cause problems.
5
“Evidence suggests that meta-bolic damage occurs at intake amounts between the level caus-ing micronutrient defciency diseases and the recommendeddietary allowances (RDA). This may result in an increase in DNAdamage, neuronal or mitochondrial decay that could lead to ac-celerated aging, cancers, and degenerative diseases.
6
Dr. BruceAmes, a respected biochemist rom the University o Caliornia,Berkeley, showed that low levels o micronutrients (vitaminsand minerals) at the cellular level may actively promote DNAand protein damage and cause disease to a larger extent thanis generally realized. The optimum amount o vitamins and min-erals that are truly required is the amount that minimizes DNAdamage and maximizes a healthy lie span, which is higher thanthe amount to prevent acute disease.
7
Dr. Ames suggests thatvitamins and minerals play a critical role as coactors in enzymereactions that protect genes rom mutations and repair genedamage. Thus, certain micronutrients can act prophylactically,and also therapeutically.Numerous clinical trials have evaluated the use o nutritionalsupplements such as beta-carotene, selenium, vitamin C andvitamin E in the prevention o coronary heart disease and strokeyielding conicting results (positive, neutral and negative). Inmany o these clinical trials there were enormous clinical designproblems, methodological aws, varied patient populations,variable doses and type o vitamin use, improper selection o vitamins used and many other issues that make the studies di-fcult to interpret.
8
The MOST study is the frst
to run the meth-odological gauntlet, solving the clinical design and therapeuticchallenges that others haven’t. This pilot study produced en-couraging and exciting results, and established the viability,and capabilities o this revolutionary research tool. The MOSTmethodology should be utilized to modernize recommendeddaily allowances, improve tolerance and saety data, promotenew ocus into micronutrient research studies, and become aormidable oe o chronic and acute disease.
Methods
We examined prospectively a cohort o active adults aged 34 to73
years (median 53.5) who were seen at a preventive medicinecenter late 2009 through early 2010. This pilot study group wasselected merely as the frst group o ten available or analysis. The group o adults, 6 men and 4 women were given a propri-etary IVitaminScience (IVS) comprehensive health history ques-tionnaire and then had their initial phlebotomy. Once their cel-lular laboratory results were completed, the data was entered,along with the nutrient history fndings into the IVS’s proprietaryalgorithm that created individual, custom, therapeutic ormulasor each participant. (See Table 1.) Thirteen individual vitamin and ten mineral components thatwere supplemented, each patient had at least 4 capsules per dayo micronutrients and were asked to take their vitamins in the AMand their minerals in the PM. Each patient was also asked to re-rain rom any other micronutrient supplement or the durationo the study. At the end o 6 months, a second phlebotomy wasperormed and the results were compared against their baseline.Blood samples were collected in two 10 ml heparinized tubesand shipped overnight to the testing acility. Upon receipt, pe-ripheral blood mononuclear cells (over 90% lymphocytes) wereisolated by Ficoll density gradient centriugation and washed toremove platelets. Lymphocytes (150,000 cells/ml) were addedto wells o microtiter plates with a series o over 60 dierentmodifcations o CFBI 1000 proprietary media, stimulated togrow by addition o phytohemagglutinin (PHA), and incubatedor our days. Tritiated thymidine was then added, and incuba-tion continued or another day. Cells were then harvested toretain DNA on flters, and a direct-read beta counter countedradioactivity. Results were expressed as a percentage o control(optimal) growth.
9
Results
This trial was not only a supplemental challenge study, but alsoan eciency study. The goals o the program were to replaceall nutrients to a reasonable abundance, without creating largeexcesses. Target abundance was determined to a cellular nu-merical value o 15 when compared against the arithmetic di-erence rom control to observed values, while defciencies weredefned as levels below 7. (See Table 1)
Add a Comment